查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1356754

乳房切片设备市场报告：2030 年趋势、预测与竞争分析

Breast Biopsy Device Market Report: Trends, Forecast and Competitive Analysis to 2030
出版日期: | 出版商: Lucintel | 英文 150 Pages | 商品交期: 3个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

乳房切片设备趋势与预测

到 2030 年，全球乳房切片设备市场预计将达到 21 亿美元，2024 年至 2030 年年复合成长率为 5.2%。该市场的主要促进因素是罹患率的增加、微创手术设备的大量使用以及对液体切片检查的日益偏好。全球乳房切片设备市场的未来前景广阔，医院、诊所、实验室、製药和生物技术市场存在商机。

乳房切片设备市场洞察

根据 Lucintel 的预测，引导系统预计将在预测期内实现最高成长，因为它是提高切片检查程序准确性和效率的关键用途。

由于越来越多地采用先进的诊断工具和熟练的专业人员来改善患者照护，医院将继续成为最大的细分市场。

由于乳癌患者数量不断增加、有吸引力的报销机会以及该地区强大的医疗基础设施，预计北美地区在预测期内将出现最高的增长。

本报告回答了 11 个关键问题：

  • Q.1. 细分市场中最有前途和高成长的机会是什么？
  • Q.2.哪个细分市场将以更快的速度成长？为什么？
  • Q.3.您认为哪些地区未来会出现更快的成长？为什么？
  • Q.4. 影响市场动态的主要要素有哪些？市场的主要挑战和商业风险是什么？
  • Q.5. 这个市场的商业风险和竞争威胁是什么？
  • Q.6.这个市场有哪些新趋势？为什么？
  • Q.7.市场客户需求有何改变？
  • Q.8. 该市场有哪些新发展以及哪些公司处于领先地位？
  • Q.9.这个市场的主要企业有哪些？主要企业采取哪些策略配合措施来发展业务？
  • Q.10. 该市场上的竞争产品有哪些，由于材料或产品替代导致市场占有率下降的威胁有多大？
  • Q.11.过去年度发生了哪些併购事件，对产业产生了哪些影响？

目录

第1章执行摘要

第2章全球乳房切片设备市场：市场动态

  • 简介、背景、分类
  • 供应链
  • 产业促进因素与挑战

第3章2018-2030年市场趋势及预测分析

  • 宏观经济趋势（2018-2023）与预测（2024-2030）
  • 全球乳房切片设备市场趋势（2018-2023）与预测（2024-2030）
  • 按类型分類的全球乳房切片设备市场
    • 切片穿刺针
    • 引导系统
    • 切片检查
    • 定位线
    • 检测试剂盒
    • 液体切片仪器
    • 其他的
  • 按程序分類的全球乳房切片设备市场
    • 乳房穿刺活检
    • 开放性手术乳房切片
    • 乳房切片
  • 全球乳房切片设备市场（按应用）
    • 早期癌症筛检
    • 治疗方法选择
    • 治疗监测
    • 监测復发情况
  • 全球乳房切片设备市场（依最终用途）
    • 医院和诊所
    • 调查
    • 製药和生物技术公司
    • 其他的

第4章2018-2030年分地区市场趋势及预测分析

  • 全球乳房切片设备市场（按地区）
  • 北美乳房切片设备市场
  • 欧洲乳房切片设备市场
  • 亚太地区乳房切片设备市场
  • 其他区域乳房切片设备市场

第5章竞争分析

  • 产品系列分析
  • 营运整合
  • 波特五力分析

第6章成长机会与策略分析

  • 成长机会分析
    • 按类型分類的全球乳房切片设备市场成长机会
    • 全球乳房切片市场成长机会（按程序）
    • 全球乳房切片设备市场成长机会（按应用）
    • 全球乳房切片设备市场成长机会（依最终用途）
    • 全球乳房切片设备市场成长机会（按地区）
  • 全球乳房切片设备市场的新兴趋势
  • 战略分析
    • 新产品开发
    • 全球乳房切片设备市场容量扩张
    • 全球乳房切片设备市场的合併、收购和合资企业
    • 认证和许可

第7章主要企业概况

  • Hologic
  • Danaher
  • Argon Medical Devices
  • Merit Medical Systems
  • Menarini-Silicon Biosystems
  • Guardant Health
  • NeoGenomics
  • Sysmex Inostics
  • Sterylab
  • Biocept
简介目录

Breast Biopsy Device Trends and Forecast

The future of the global breast biopsy device market looks promising with opportunities in the hospital & clinic, research laboratory, and pharmaceutical & biotechnology markets. The global breast biopsy device market is expected to reach an estimated $2.1 billion by 2030 with a CAGR of 5.2% from 2024 to 2030. The major drivers for this market are growing incidence of breast cancer, significant use of this device to enable less intrusive techniques, and rising preference for liquid biopsy.

A more than 150-page report is developed to help in your business decisions.

Breast Biopsy Device by Segment

The study includes a forecast for the global breast biopsy device by type, procedure, application, end use, and region.

Breast Biopsy Device Market by Type [Shipment Analysis by Value from 2018 to 2030]:

  • Biopsy Needles
  • Guidance Systems
  • Biopsy Tables
  • Localization Wires
  • Assay Kits
  • Liquid Biopsy Instruments
  • Others

Breast Biopsy Device Market by Procedure [Shipment Analysis by Value from 2018 to 2030]:

  • Needle Breast Biopsy
  • Open Surgical Breast Biopsy
  • Liquid Breast Biopsy

Breast Biopsy Device Market by Application [Shipment Analysis by Value from 2018 to 2030]:

  • Early Cancer Screening
  • Therapy Selection
  • Treatment Monitoring
  • Recurrence Monitoring

Breast Biopsy Device Market by End Use [Shipment Analysis by Value from 2018 to 2030]:

  • Hospitals & Clinics
  • Research Laboratories
  • Pharmaceutical & Biotechnology Companies
  • Others

Breast Biopsy Device Market by Region [Shipment Analysis by Value from 2018 to 2030]:

  • North America
  • Europe
  • Asia Pacific
  • The Rest of the World

List of Breast Biopsy Device Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies breast biopsy device companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the breast biopsy device companies profiled in this report include-

  • Hologic
  • Danaher
  • Argon Medical Devices
  • Merit Medical Systems
  • Menarini-Silicon Biosystems
  • Guardant Health
  • Neogenomics
  • Sysmex Inostics
  • Sterylab
  • Biocept

Breast Biopsy Device Market Insights

Lucintel forecasts that guidance system is expected to witness highest growth over the forecast period due to its significant use in enhancing the accuracy and efficiency of biopsy procedures.

Hospital will remain the largest segment due to the rising adoption of advanced diagnostic tools and skilled professionals to improve patient care in this setting.

North America is expected to witness highest growth over the forecast period due to rising breast cancer cases, availability of attractive reimbursement opportunities, and presence of robust healthcare infrastructure in the region.

Features of the Global Breast Biopsy Device Market

Market Size Estimates: Breast biopsy device market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Breast biopsy device market by various segments, such as by type, procedure, application, end use and region in terms of($B).

Regional Analysis: Breast biopsy device market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different types, procedures, applications, end uses, and region.s for the breast biopsy device market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the breast biopsy device market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q.1. What is the breast biopsy device market size?

Answer: The global breast biopsy device market is expected to reach an estimated $2.1 billion by 2030.

Q.2. What is the growth forecast for breast biopsy device market?

Answer: The global breast biopsy device market is expected to grow with a CAGR of 5.2% from 2024 to 2030.

Q.3. What are the major drivers influencing the growth of the breast biopsy device market?

Answer: The major drivers for this market are growing incidence of breast cancer, significant use of this device to enable less intrusive techniques, and rising preference for liquid biopsy.

Q.4. What are the major segments for breast biopsy device market?

Answer: The future of the breast biopsy device market looks promising with opportunities in the hospital & clinic, research laboratory, and pharmaceutical & biotechnology markets.

Q.5. Who are the key breast biopsy device market companies?

Answer: Some of the key breast biopsy device companies are as follows:

  • Hologic
  • Danaher
  • Argon Medical Devices
  • Merit Medical Systems
  • Menarini-Silicon Biosystems
  • Guardant Health
  • NeoGenomics
  • Sysmex Inostics
  • Sterylab
  • Biocept

Q.6. Which breast biopsy device market segment will be the largest in future?

Answer: Lucintel forecasts that guidance system is expected to witness highest growth over the forecast period due to its significant use in enhancing the accuracy and efficiency of biopsy procedures.

Q.7. In breast biopsy device market, which region is expected to be the largest in next 5 years?

Answer: North America is expected to witness highest growth over the forecast period due to rising breast cancer cases, availability of attractive reimbursement opportunities, and presence of robust healthcare infrastructure in the region.

Q.8. Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

  • Q.1. What are some of the most promising, high-growth opportunities for the breast biopsy device market by type (biopsy needles, guidance systems, biopsy tables, localization wires, assay kits, liquid biopsy instruments, and others), procedure (needle breast biopsy, open surgical breast biopsy, and liquid breast biopsy), application (early cancer screening, therapy selection, treatment monitoring, and recurrence monitoring), end use (hospitals & clinics, research laboratories, pharmaceutical & biotechnology companies, and others), and region. (North America, Europe, Asia Pacific, and the Rest of the World)?
  • Q.2. Which segments will grow at a faster pace and why?
  • Q.3. Which region will grow at a faster pace and why?
  • Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
  • Q.5. What are the business risks and competitive threats in this market?
  • Q.6. What are the emerging trends in this market and the reasons behind them?
  • Q.7. What are some of the changing demands of customers in the market?
  • Q.8. What are the new developments in the market? Which companies are leading these developments?
  • Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
  • Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
  • Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Breast Biopsy Device Market: Market Dynamics

  • 2.1: Introduction, Background, and Classifications
  • 2.2: Supply Chain
  • 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

  • 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
  • 3.2. Global Breast Biopsy Device Market Trends (2018-2023) and Forecast (2024-2030)
  • 3.3: Global Breast Biopsy Device Market by Type
    • 3.3.1: Biopsy Needles
    • 3.3.2: Guidance Systems
    • 3.3.3: Biopsy Tables
    • 3.3.4: Localization Wires
    • 3.3.5: Assay Kits
    • 3.3.6: Liquid Biopsy Instruments
    • 3.3.7: Others
  • 3.4: Global Breast Biopsy Device Market by Procedure
    • 3.4.1: Needle Breast Biopsy
    • 3.4.2: Open Surgical Breast Biopsy
    • 3.4.3: Liquid Breast Biopsy
  • 3.5: Global Breast Biopsy Device Market by Application
    • 3.5.1: Early Cancer Screening
    • 3.5.2: Therapy Selection
    • 3.5.3: Treatment Monitoring
    • 3.5.4: Recurrence Monitoring
  • 3.6: Global Breast Biopsy Device Market by End Use
    • 3.6.1: Hospitals & Clinics
    • 3.6.2: Research Laboratories
    • 3.6.3: Pharmaceutical & Biotechnology Companies
    • 3.6.4: Others

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

  • 4.1: Global Breast Biopsy Device Market by Region
  • 4.2: North American Breast Biopsy Device Market
    • 4.2.2: North American Breast Biopsy Device Market by End Use: Hospitals & Clinics, Research Laboratories, Pharmaceutical & Biotechnology Companies, and Others
  • 4.3: European Breast Biopsy Device Market
    • 4.3.1: European Breast Biopsy Device Market by Type: Biopsy Needles, Guidance Systems, Biopsy Tables,Localization Wires, Assay Kits, Liquid Biopsy Instruments, and Others
    • 4.3.2: European Breast Biopsy Device Market by End Use: Hospitals & Clinics, Research Laboratories, Pharmaceutical & Biotechnology Companies, and Others
  • 4.4: APAC Breast Biopsy Device Market
    • 4.4.1: APAC Breast Biopsy Device Market by Type: Biopsy Needles, Guidance Systems, Biopsy Tables,Localization Wires, Assay Kits, Liquid Biopsy Instruments, and Others
    • 4.4.2: APAC Breast Biopsy Device Market by End Use: Hospitals & Clinics, Research Laboratories, Pharmaceutical & Biotechnology Companies, and Others
  • 4.5: ROW Breast Biopsy Device Market
    • 4.5.1: ROW Breast Biopsy Device Market by Type: Biopsy Needles, Guidance Systems, Biopsy Tables,Localization Wires, Assay Kits, Liquid Biopsy Instruments, and Others
    • 4.5.2: ROW Breast Biopsy Device Market by End Use: Hospitals & Clinics, Research Laboratories, Pharmaceutical & Biotechnology Companies, and Others

5. Competitor Analysis

  • 5.1: Product Portfolio Analysis
  • 5.2: Operational Integration
  • 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

  • 6.1: Growth Opportunity Analysis
    • 6.1.1: Growth Opportunities for the Global Breast Biopsy Device Market by Type
    • 6.1.2: Growth Opportunities for the Global Breast Biopsy Device Market by Procedure
    • 6.1.3: Growth Opportunities for the Global Breast Biopsy Device Market by Application
    • 6.1.4: Growth Opportunities for the Global Breast Biopsy Device Market by End Use
    • 6.1.5: Growth Opportunities for the Global Breast Biopsy Device Market by Region
  • 6.2: Emerging Trends in the Global Breast Biopsy Device Market
  • 6.3: Strategic Analysis
    • 6.3.1: New Product Development
    • 6.3.2: Capacity Expansion of the Global Breast Biopsy Device Market
    • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Breast Biopsy Device Market
    • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

  • 7.1: Hologic
  • 7.2: Danaher
  • 7.3: Argon Medical Devices
  • 7.4: Merit Medical Systems
  • 7.5: Menarini-Silicon Biosystems
  • 7.6: Guardant Health
  • 7.7: NeoGenomics
  • 7.8: Sysmex Inostics
  • 7.9: Sterylab
  • 7.10: Biocept